(Q44185659)

30 November 2017

title

Estradiol reduces F2alpha-isoprostane production in cultured human endothelial cells (English)

1 reference

30 November 2017

0 references

4

Antonio Cano

1 reference

30 November 2017

3

Juan J Tarín

1 reference

30 November 2017

Carlos Hermenegildo

1

1 reference

30 November 2017

María Cinta García-Martínez

series ordinal

2

1 reference

30 November 2017

publication date

26 July 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

30 November 2017

published in

1 reference

30 November 2017

volume

283

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

H2644-9

1 reference

Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Oxygen radicals and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

21 January 2018

Pure anti-oestrogens.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

The effect of oral hormone replacement therapy on lipoprotein profile, resistance of LDL to oxidation and LDL particle size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Temporal effects of 17beta-estradiol on caveolin-1 mRNA and protein in bovine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Differential effects of subcutaneous estrogen and progesterone on low-density lipoprotein size and susceptibility to oxidation in postmenopausal rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

The protective effects of estrogen on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Estrogen receptors: orchestrators of pleiotropic cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Antioxidant and prooxidant actions of estrogens: potential physiological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

6-oxo-PGF(1 alpha)and 8-epi-PGF(2 alpha)in the arterial wall layers of various species: a comparison between intact and atherosclerotic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Effects of some isoprostanes on the human umbilical artery in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

The differential effects of oestrogens and progestins on vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Endothelium-derived free radicals: for worse and for better

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

Placental isoprostane is significantly increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

17Beta-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00369.2002

10.1152/AJPHEART.00369.2002

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference